Abingworth management ltd - by abingworth bioequities master fund limited investment history in Xenogen corp

Filed on 2006-08-14 by Abingworth Management Ltd SEC CIK 1291892 Form 4

Accession 0001181431-06-047234.txt Sec File: edgar/data/1291892/0001181431-06-047234-index.htm

2006-08-09 Abingworth Management Ltd (CIK 1291892) through By Abingworth Bioequities Master Fund Limited

Invested in Xenogen Corp sold 154639 shares at $0 remaining shares owned 0

Warrant Right To Buy Xenogen Corp Xgen exercise date 2006-02-15 exercise price 3.29 has valueitem expiration due date 2010-08-15 underlying security shares 154639 underlying security title Common Stock

f2 this warrant was assumed by caliper in the merger and replaced with a warrant to purchase .5792 shares of caliper common stock for each issuer warrant share at an exercise price of $4.84 (closing sale price) per share.


Filed on 2006-08-14 by Abingworth Management Ltd SEC CIK 1291892 Form 4

Accession 0001181431-06-047234.txt Sec File: edgar/data/1291892/0001181431-06-047234-index.htm

2006-08-09 Abingworth Management Ltd (CIK 1291892) through By Abingworth Bioequities Master Fund Limited

Invested in Xenogen Corp sold 15715 shares at $0 remaining shares owned 0

Common Stock Xenogen Corp Xgen Transaction code: D Sale (or disposition) back to the issuer of the securities

f1 disposed of pursuant to an agreement and plan of merger between the issuer, caliper life sciences, inc. ("caliper") and caliper holdings, inc. (the "merger"). in exchange for each share of issuer common stock, stockholders of the issuer received .5792 shares of caliper common stock, having a market value of $4.84 (the closing sale price) per share on the effective date of the merger and a warrant to purchase .2249 of a share of caliper common stock.


Filed on 2006-08-14 by Abingworth Management Ltd SEC CIK 1291892 Form 4

Accession 0001181431-06-047234.txt Sec File: edgar/data/1291892/0001181431-06-047234-index.htm

2006-08-09 Abingworth Management Ltd (CIK 1291892) through By Abingworth Bioequities Master Fund Limited

Invested in Xenogen Corp sold 515464 shares at $0 remaining shares owned 0

Common Stock Xenogen Corp Xgen Transaction code: D Sale (or disposition) back to the issuer of the securities

f1 disposed of pursuant to an agreement and plan of merger between the issuer, caliper life sciences, inc. ("caliper") and caliper holdings, inc. (the "merger"). in exchange for each share of issuer common stock, stockholders of the issuer received .5792 shares of caliper common stock, having a market value of $4.84 (the closing sale price) per share on the effective date of the merger and a warrant to purchase .2249 of a share of caliper common stock.


Filed on 2006-08-14 by Abingworth Management Ltd SEC CIK 1291892 Form 4

Accession 0001181431-06-047234.txt Sec File: edgar/data/1291892/0001181431-06-047234-index.htm

2006-08-09 Abingworth Management Ltd (CIK 1291892) through By Abingworth Bioequities Master Fund Limited

Invested in Xenogen Corp sold 20719 shares at $0 remaining shares owned 0

Common Stock Xenogen Corp Xgen Transaction code: D Sale (or disposition) back to the issuer of the securities

f1 disposed of pursuant to an agreement and plan of merger between the issuer, caliper life sciences, inc. ("caliper") and caliper holdings, inc. (the "merger"). in exchange for each share of issuer common stock, stockholders of the issuer received .5792 shares of caliper common stock, having a market value of $4.84 (the closing sale price) per share on the effective date of the merger and a warrant to purchase .2249 of a share of caliper common stock.


Filed on 2006-08-14 by Abingworth Management Ltd SEC CIK 1291892 Form 4

Accession 0001181431-06-047234.txt Sec File: edgar/data/1291892/0001181431-06-047234-index.htm

2006-08-09 Abingworth Management Ltd (CIK 1291892) through By Abingworth Bioequities Master Fund Limited

Invested in Xenogen Corp sold 475398 shares at $0 remaining shares owned 0

Common Stock Xenogen Corp Xgen Transaction code: D Sale (or disposition) back to the issuer of the securities

f1 disposed of pursuant to an agreement and plan of merger between the issuer, caliper life sciences, inc. ("caliper") and caliper holdings, inc. (the "merger"). in exchange for each share of issuer common stock, stockholders of the issuer received .5792 shares of caliper common stock, having a market value of $4.84 (the closing sale price) per share on the effective date of the merger and a warrant to purchase .2249 of a share of caliper common stock.


Filed on 2006-08-14 by Abingworth Management Ltd SEC CIK 1291892 Form 4

Accession 0001181431-06-047234.txt Sec File: edgar/data/1291892/0001181431-06-047234-index.htm

2006-08-09 Abingworth Management Ltd (CIK 1291892) through By Abingworth Bioequities Master Fund Limited

Invested in Xenogen Corp sold 793641 shares at $0 remaining shares owned 0

Common Stock Xenogen Corp Xgen Transaction code: D Sale (or disposition) back to the issuer of the securities

f1 disposed of pursuant to an agreement and plan of merger between the issuer, caliper life sciences, inc. ("caliper") and caliper holdings, inc. (the "merger"). in exchange for each share of issuer common stock, stockholders of the issuer received .5792 shares of caliper common stock, having a market value of $4.84 (the closing sale price) per share on the effective date of the merger and a warrant to purchase .2249 of a share of caliper common stock.


Filed on 2006-08-14 by Abingworth Management Ltd SEC CIK 1291892 Form 4

Accession 0001181431-06-047234.txt Sec File: edgar/data/1291892/0001181431-06-047234-index.htm

2006-08-09 Abingworth Management Ltd (CIK 1291892) through By Abingworth Bioequities Master Fund Limited

Invested in Xenogen Corp sold 1300117 shares at $0 remaining shares owned 0

Common Stock Xenogen Corp Xgen Transaction code: D Sale (or disposition) back to the issuer of the securities

f1 disposed of pursuant to an agreement and plan of merger between the issuer, caliper life sciences, inc. ("caliper") and caliper holdings, inc. (the "merger"). in exchange for each share of issuer common stock, stockholders of the issuer received .5792 shares of caliper common stock, having a market value of $4.84 (the closing sale price) per share on the effective date of the merger and a warrant to purchase .2249 of a share of caliper common stock.


Filed on 2005-08-15 by Abingworth Management Ltd SEC CIK 1291892 Form 4

Accession 0001181431-05-046917.txt Sec File: edgar/data/1291892/0001181431-05-046917-index.htm

2005-08-11 Abingworth Management Ltd (CIK 1291892) through By Abingworth Bioequities Master Fund Limited

Invested in Xenogen Corp bought 154639 shares at $0 remaining shares owned 154639

Warrant Right To Buy Xenogen Corp Xgen exercise date 2006-02-15 exercise price 3.29 has valueitem expiration due date 2010-08-15 underlying security shares 154639 underlying security title Common Stock


Filed on 2005-08-15 by Abingworth Management Ltd SEC CIK 1291892 Form 4

Accession 0001181431-05-046917.txt Sec File: edgar/data/1291892/0001181431-05-046917-index.htm

2005-08-11 Abingworth Management Ltd (CIK 1291892) through By Abingworth Bioequities Master Fund Limited

Invested in Xenogen Corp bought 515464 shares at $2.91 remaining shares owned 515464

Common Stock Xenogen Corp Xgen Transaction code: P Open market or private purchase of securities


Filed on 2005-08-15 by Abingworth Management Ltd SEC CIK 1291892 Form 4

Accession 0001181431-05-046917.txt Sec File: edgar/data/1291892/0001181431-05-046917-index.htm

2005-08-11 Abingworth Management Ltd (CIK 1291892) through By Abingworth Bioequities Master Fund Limited

Invested in Xenogen Corp bought 6873 shares at $2.91 remaining shares owned 20719

Common Stock Xenogen Corp Xgen Transaction code: P Open market or private purchase of securities


Filed on 2005-08-15 by Abingworth Management Ltd SEC CIK 1291892 Form 4

Accession 0001181431-05-046917.txt Sec File: edgar/data/1291892/0001181431-05-046917-index.htm

2005-08-11 Abingworth Management Ltd (CIK 1291892) through By Abingworth Bioequities Master Fund Limited

Invested in Xenogen Corp bought 157698 shares at $2.91 remaining shares owned 475398

Common Stock Xenogen Corp Xgen Transaction code: P Open market or private purchase of securities


Filed on 2005-08-15 by Abingworth Management Ltd SEC CIK 1291892 Form 4

Accession 0001181431-05-046917.txt Sec File: edgar/data/1291892/0001181431-05-046917-index.htm

2005-08-11 Abingworth Management Ltd (CIK 1291892) through By Abingworth Bioequities Master Fund Limited

Invested in Xenogen Corp bought 263265 shares at $2.91 remaining shares owned 793641

Common Stock Xenogen Corp Xgen Transaction code: P Open market or private purchase of securities


Filed on 2005-08-15 by Abingworth Management Ltd SEC CIK 1291892 Form 4

Accession 0001181431-05-046917.txt Sec File: edgar/data/1291892/0001181431-05-046917-index.htm

2005-08-11 Abingworth Management Ltd (CIK 1291892) through By Abingworth Bioequities Master Fund Limited

Invested in Xenogen Corp bought 431271 shares at $2.91 remaining shares owned 1300117

Common Stock Xenogen Corp Xgen Transaction code: P Open market or private purchase of securities


Filed on 2005-08-15 by Abingworth Management Ltd SEC CIK 1291892 Form 4

Accession 0001181431-05-046917.txt Sec File: edgar/data/1291892/0001181431-05-046917-index.htm

2005-08-11 Abingworth Management Ltd (CIK 1291892) through By Abingworth Bioequities Master Fund Limited

Invested in Xenogen Corp remaining shares owned 15715

Common Stock Xenogen Corp Xgen